An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

Flow-chart depicting the study drug progression steps (SI, selectivity

Chagas Disease: A Review of the Disease and Interaction with COVID-19

Cardiac involvement in African and American trypanosomiasis - The Lancet Infectious Diseases

Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions - The Lancet Microbe

An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

Frontiers Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease

Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts

PDF] Drug Discovery for Kinetoplastid Diseases: Future Directions.

Chagas Disease Drug Discovery

Antiproliferative effect of Pd-dppf-mpo in T. cruzi epimastigotes. a

A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease

Full article: Animal models of Chagas disease and their translational value to drug development

Putting Infection Dynamics at the Heart of Chagas Disease: Trends in Parasitology